

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.93719597 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.93719597 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.91542856 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.91542856 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.30731817 |
| 6 | glyoxylate metabolic process (GO:0046487) | 6.16304611 |
| 7 | cysteine metabolic process (GO:0006534) | 5.76826251 |
| 8 | tryptophan catabolic process (GO:0006569) | 5.75829939 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 5.75829939 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 5.75829939 |
| 11 | * sulfur amino acid catabolic process (GO:0000098) | 5.59568692 |
| 12 | bile acid biosynthetic process (GO:0006699) | 5.50808529 |
| 13 | kynurenine metabolic process (GO:0070189) | 5.47209503 |
| 14 | tryptophan metabolic process (GO:0006568) | 5.38748780 |
| 15 | behavioral response to nicotine (GO:0035095) | 5.31115831 |
| 16 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.14280301 |
| 17 | serine family amino acid catabolic process (GO:0009071) | 5.13297723 |
| 18 | lysine catabolic process (GO:0006554) | 5.09461403 |
| 19 | lysine metabolic process (GO:0006553) | 5.09461403 |
| 20 | alpha-linolenic acid metabolic process (GO:0036109) | 5.07822051 |
| 21 | homocysteine metabolic process (GO:0050667) | 4.99252081 |
| 22 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.94739948 |
| 23 | complement activation, alternative pathway (GO:0006957) | 4.90494990 |
| 24 | bile acid metabolic process (GO:0008206) | 4.72594663 |
| 25 | urea cycle (GO:0000050) | 4.69434667 |
| 26 | urea metabolic process (GO:0019627) | 4.69434667 |
| 27 | amino-acid betaine metabolic process (GO:0006577) | 4.64671963 |
| 28 | aromatic amino acid family metabolic process (GO:0009072) | 4.62225520 |
| 29 | acetyl-CoA metabolic process (GO:0006084) | 4.60160099 |
| 30 | regulation of protein activation cascade (GO:2000257) | 4.60050526 |
| 31 | proline metabolic process (GO:0006560) | 4.49055881 |
| 32 | negative regulation of fibrinolysis (GO:0051918) | 4.44766893 |
| 33 | acylglycerol homeostasis (GO:0055090) | 4.44073229 |
| 34 | triglyceride homeostasis (GO:0070328) | 4.44073229 |
| 35 | nitrogen cycle metabolic process (GO:0071941) | 4.41387510 |
| 36 | alpha-amino acid catabolic process (GO:1901606) | 4.41279495 |
| 37 | regulation of complement activation (GO:0030449) | 4.37511229 |
| 38 | fatty acid beta-oxidation (GO:0006635) | 4.37296699 |
| 39 | drug transmembrane transport (GO:0006855) | 4.33801599 |
| 40 | regulation of fibrinolysis (GO:0051917) | 4.32109446 |
| 41 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.30164517 |
| 42 | protein carboxylation (GO:0018214) | 4.30164517 |
| 43 | serine family amino acid metabolic process (GO:0009069) | 4.24947023 |
| 44 | regulation of triglyceride catabolic process (GO:0010896) | 4.23655018 |
| 45 | high-density lipoprotein particle remodeling (GO:0034375) | 4.23328484 |
| 46 | tyrosine metabolic process (GO:0006570) | 4.23057998 |
| 47 | urate metabolic process (GO:0046415) | 4.22333826 |
| 48 | short-chain fatty acid metabolic process (GO:0046459) | 4.22188920 |
| 49 | cellular ketone body metabolic process (GO:0046950) | 4.21764610 |
| 50 | * cellular amino acid catabolic process (GO:0009063) | 4.21328136 |
| 51 | fatty acid oxidation (GO:0019395) | 4.18725440 |
| 52 | lipid oxidation (GO:0034440) | 4.09629947 |
| 53 | cellular modified amino acid catabolic process (GO:0042219) | 4.08663278 |
| 54 | NAD biosynthetic process (GO:0009435) | 4.08516848 |
| 55 | fatty acid catabolic process (GO:0009062) | 4.05787744 |
| 56 | coenzyme catabolic process (GO:0009109) | 4.04888866 |
| 57 | ethanol oxidation (GO:0006069) | 4.02398323 |
| 58 | amine catabolic process (GO:0009310) | 4.00407834 |
| 59 | cellular biogenic amine catabolic process (GO:0042402) | 4.00407834 |
| 60 | proline biosynthetic process (GO:0006561) | 4.00120567 |
| 61 | valine metabolic process (GO:0006573) | 3.99780321 |
| 62 | indolalkylamine metabolic process (GO:0006586) | 3.99013740 |
| 63 | regulation of sequestering of triglyceride (GO:0010889) | 3.95679063 |
| 64 | glutamate metabolic process (GO:0006536) | 3.93380168 |
| 65 | cytolysis (GO:0019835) | 3.93247827 |
| 66 | * organic acid catabolic process (GO:0016054) | 3.89787687 |
| 67 | * carboxylic acid catabolic process (GO:0046395) | 3.89787687 |
| 68 | monocarboxylic acid catabolic process (GO:0072329) | 3.89714347 |
| 69 | glycine metabolic process (GO:0006544) | 3.84256534 |
| 70 | benzene-containing compound metabolic process (GO:0042537) | 3.83139775 |
| 71 | plasma lipoprotein particle clearance (GO:0034381) | 3.80327595 |
| 72 | regulation of cholesterol homeostasis (GO:2000188) | 3.79534688 |
| 73 | 2-oxoglutarate metabolic process (GO:0006103) | 3.74703342 |
| 74 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.73264815 |
| 75 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.73096577 |
| 76 | serine family amino acid biosynthetic process (GO:0009070) | 3.72015475 |
| 77 | cellular glucuronidation (GO:0052695) | 3.71994045 |
| 78 | biotin metabolic process (GO:0006768) | 3.71585409 |
| 79 | reverse cholesterol transport (GO:0043691) | 3.70330645 |
| 80 | drug catabolic process (GO:0042737) | 3.69992477 |
| 81 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.68744127 |
| 82 | branched-chain amino acid metabolic process (GO:0009081) | 3.68575917 |
| 83 | heme transport (GO:0015886) | 3.67926771 |
| 84 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.67513191 |
| 85 | plasma lipoprotein particle remodeling (GO:0034369) | 3.65250695 |
| 86 | protein-lipid complex remodeling (GO:0034368) | 3.65250695 |
| 87 | macromolecular complex remodeling (GO:0034367) | 3.65250695 |
| 88 | branched-chain amino acid catabolic process (GO:0009083) | 3.64980471 |
| 89 | ketone body metabolic process (GO:1902224) | 3.64309596 |
| 90 | carnitine metabolic process (GO:0009437) | 3.63931372 |
| 91 | regulation of cholesterol esterification (GO:0010872) | 3.63733681 |
| 92 | response to nitrosative stress (GO:0051409) | 3.61381661 |
| 93 | aspartate family amino acid catabolic process (GO:0009068) | 3.59996706 |
| 94 | drug transport (GO:0015893) | 3.57348740 |
| 95 | bile acid and bile salt transport (GO:0015721) | 3.56996181 |
| 96 | fucose catabolic process (GO:0019317) | 3.50750308 |
| 97 | L-fucose metabolic process (GO:0042354) | 3.50750308 |
| 98 | L-fucose catabolic process (GO:0042355) | 3.50750308 |
| 99 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.48447899 |
| 100 | cholesterol efflux (GO:0033344) | 3.48089560 |
| 101 | negative regulation of sterol transport (GO:0032372) | 3.46436924 |
| 102 | negative regulation of cholesterol transport (GO:0032375) | 3.46436924 |
| 103 | cholesterol homeostasis (GO:0042632) | 3.45289971 |
| 104 | plasma lipoprotein particle assembly (GO:0034377) | 3.44734104 |
| 105 | positive regulation of CREB transcription factor activity (GO:0032793) | 3.42701822 |
| 106 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.41996208 |
| 107 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.41996208 |
| 108 | sterol homeostasis (GO:0055092) | 3.40760421 |
| 109 | macroautophagy (GO:0016236) | 3.25445876 |
| 110 | response to pheromone (GO:0019236) | 3.21529729 |
| 111 | somite development (GO:0061053) | 3.12434358 |
| 112 | behavioral response to ethanol (GO:0048149) | 3.04798531 |
| 113 | nucleobase catabolic process (GO:0046113) | 3.04508830 |
| 114 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.03691033 |
| 115 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.99569038 |
| 116 | positive regulation of fatty acid oxidation (GO:0046321) | 2.93636357 |
| 117 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.92870225 |
| 118 | adaptation of signaling pathway (GO:0023058) | 2.92563348 |
| 119 | positive regulation of histone deacetylation (GO:0031065) | 2.92522962 |
| 120 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.90613815 |
| 121 | gamma-aminobutyric acid transport (GO:0015812) | 2.87969710 |
| 122 | startle response (GO:0001964) | 2.84688482 |
| 123 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.82048213 |
| 124 | negative regulation of interleukin-1 production (GO:0032692) | 2.80460056 |
| 125 | detection of bacterium (GO:0016045) | 2.77688965 |
| 126 | neuronal action potential (GO:0019228) | 2.74012846 |
| 127 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.72324575 |
| 128 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 2.70763936 |
| 129 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.69060764 |
| 130 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.67899515 |
| 131 | response to misfolded protein (GO:0051788) | 2.65117148 |
| 132 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.64766708 |
| 133 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.64766708 |
| 134 | detection of other organism (GO:0098543) | 2.61210780 |
| 135 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.60283481 |
| 136 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.59506043 |
| 137 | reciprocal DNA recombination (GO:0035825) | 2.59071053 |
| 138 | reciprocal meiotic recombination (GO:0007131) | 2.59071053 |
| 139 | exogenous drug catabolic process (GO:0042738) | 2.57266944 |
| 140 | nephron tubule morphogenesis (GO:0072078) | 2.53684920 |
| 141 | nephron epithelium morphogenesis (GO:0072088) | 2.53684920 |
| 142 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.48468078 |
| 143 | head development (GO:0060322) | 2.47976318 |
| 144 | cAMP catabolic process (GO:0006198) | 2.46124543 |
| 145 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.45056470 |
| 146 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.44244582 |
| 147 | membrane depolarization during action potential (GO:0086010) | 2.43591598 |
| 148 | activated T cell proliferation (GO:0050798) | 2.43404286 |
| 149 | regulation of natural killer cell differentiation (GO:0032823) | 2.41472771 |
| 150 | regulation of triglyceride metabolic process (GO:0090207) | 2.36161192 |
| 151 | alanine transport (GO:0032328) | 2.36025621 |
| 152 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.35984008 |
| 153 | white fat cell differentiation (GO:0050872) | 2.35862849 |
| 154 | male sex determination (GO:0030238) | 2.35612899 |
| 155 | positive regulation of protein kinase C signaling (GO:0090037) | 2.33608205 |
| 156 | regulation of histone deacetylation (GO:0031063) | 2.31987129 |
| 157 | pyridine-containing compound biosynthetic process (GO:0072525) | 2.26703509 |
| 158 | synaptic transmission, cholinergic (GO:0007271) | 2.25544815 |
| 159 | cell migration in hindbrain (GO:0021535) | 2.25354284 |
| 160 | toxin metabolic process (GO:0009404) | 2.24575947 |
| 161 | diacylglycerol metabolic process (GO:0046339) | 2.24094026 |
| 162 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.23503342 |
| 163 | S-adenosylmethionine metabolic process (GO:0046500) | 2.21665810 |
| 164 | detection of light stimulus involved in visual perception (GO:0050908) | 2.20724152 |
| 165 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.20724152 |
| 166 | cAMP metabolic process (GO:0046058) | 2.20537661 |
| 167 | fucosylation (GO:0036065) | 2.19304838 |
| 168 | cornea development in camera-type eye (GO:0061303) | 2.18582887 |
| 169 | opioid receptor signaling pathway (GO:0038003) | 2.18452593 |
| 170 | N-acetylglucosamine metabolic process (GO:0006044) | 2.18337463 |
| 171 | epithelial cilium movement (GO:0003351) | 2.18318609 |
| 172 | alkaloid metabolic process (GO:0009820) | 2.18179916 |
| 173 | brown fat cell differentiation (GO:0050873) | 2.17121177 |
| 174 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.17042505 |
| 175 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.16722039 |
| 176 | sex determination (GO:0007530) | 2.15377381 |
| 177 | nonmotile primary cilium assembly (GO:0035058) | 2.14977369 |
| 178 | neuron cell-cell adhesion (GO:0007158) | 2.14550878 |
| 179 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.12697406 |
| 180 | axoneme assembly (GO:0035082) | 2.12389081 |
| 181 | negative regulation of mast cell activation (GO:0033004) | 2.11923106 |
| 182 | cAMP biosynthetic process (GO:0006171) | 2.11775815 |
| 183 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.11089974 |
| 184 | membrane hyperpolarization (GO:0060081) | 2.11088465 |
| 185 | cyclic nucleotide catabolic process (GO:0009214) | 2.10290547 |
| 186 | detection of biotic stimulus (GO:0009595) | 2.09849930 |
| 187 | fatty acid transmembrane transport (GO:1902001) | 2.09544299 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.71649898 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.52527933 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.00501734 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.93143561 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.52758406 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.91355389 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.28575877 |
| 8 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.17464906 |
| 9 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.92631151 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.74006353 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.50252443 |
| 12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.74878491 |
| 13 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.53202951 |
| 14 | VDR_22108803_ChIP-Seq_LS180_Human | 2.30378150 |
| 15 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.28218678 |
| 16 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.01350512 |
| 17 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.01030131 |
| 18 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.1555100 |
| 19 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.90641514 |
| 20 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.85775211 |
| 21 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.83384332 |
| 22 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.73123426 |
| 23 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.69355073 |
| 24 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.68872722 |
| 25 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.67943116 |
| 26 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.65988916 |
| 27 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.65753976 |
| 28 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.63655494 |
| 29 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.63109185 |
| 30 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.60750858 |
| 31 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.59225413 |
| 32 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.55727967 |
| 33 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.55460813 |
| 34 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.54972656 |
| 35 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.53875636 |
| 36 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.50626645 |
| 37 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.49131112 |
| 38 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.45477042 |
| 39 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.45411888 |
| 40 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.40987066 |
| 41 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.40414406 |
| 42 | ERA_21632823_ChIP-Seq_H3396_Human | 1.37718580 |
| 43 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.37506411 |
| 44 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.36744752 |
| 45 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.36198288 |
| 46 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.35972175 |
| 47 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.35438342 |
| 48 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.35278855 |
| 49 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.35152217 |
| 50 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.34257217 |
| 51 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.32968288 |
| 52 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.32896117 |
| 53 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.32896117 |
| 54 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.30785291 |
| 55 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.30132655 |
| 56 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.29865924 |
| 57 | * GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.29767333 |
| 58 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.29664224 |
| 59 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.29581981 |
| 60 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.28715731 |
| 61 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.27523299 |
| 62 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26997028 |
| 63 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.26885973 |
| 64 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.26504237 |
| 65 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.26282805 |
| 66 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.25890450 |
| 67 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.25439553 |
| 68 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.25267134 |
| 69 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.23911161 |
| 70 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.22432172 |
| 71 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.21603525 |
| 72 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.21065017 |
| 73 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.21015047 |
| 74 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.20880036 |
| 75 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.19233725 |
| 76 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.19233725 |
| 77 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.18464323 |
| 78 | NCOR_22424771_ChIP-Seq_293T_Human | 1.18390356 |
| 79 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.18344880 |
| 80 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.18048357 |
| 81 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.17655959 |
| 82 | * OCT4_20526341_ChIP-Seq_ESCs_Human | 1.17557595 |
| 83 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.15632699 |
| 84 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.15001229 |
| 85 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.14038833 |
| 86 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.13127485 |
| 87 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.12825113 |
| 88 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.12488057 |
| 89 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.12371487 |
| 90 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.11735979 |
| 91 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.10031364 |
| 92 | AR_25329375_ChIP-Seq_VCAP_Human | 1.09826916 |
| 93 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.09477218 |
| 94 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.09111759 |
| 95 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.07618840 |
| 96 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.06121184 |
| 97 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.05703653 |
| 98 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.05644992 |
| 99 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.05601956 |
| 100 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.05397923 |
| 101 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.04920561 |
| 102 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.04200647 |
| 103 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.03501191 |
| 104 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.03489129 |
| 105 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.03162342 |
| 106 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.03162342 |
| 107 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.03162342 |
| 108 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03121230 |
| 109 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.03117057 |
| 110 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.02830887 |
| 111 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.02775682 |
| 112 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.02275471 |
| 113 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.01233179 |
| 114 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.01032162 |
| 115 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.00587103 |
| 116 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.99440967 |
| 117 | TP53_16413492_ChIP-PET_HCT116_Human | 0.98070863 |
| 118 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.97981914 |
| 119 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.97247702 |
| 120 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.97209814 |
| 121 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.95647317 |
| 122 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.94326504 |
| 123 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.94262841 |
| 124 | P68_20966046_ChIP-Seq_HELA_Human | 0.94058148 |
| 125 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.93924084 |
| 126 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.93253221 |
| 127 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.93218639 |
| 128 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.93217790 |
| 129 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.92995296 |
| 130 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.92062151 |
| 131 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.91971656 |
| 132 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.90907967 |
| 133 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.90827454 |
| 134 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.90763453 |
| 135 | TCF4_23295773_ChIP-Seq_U87_Human | 0.90663521 |
| 136 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.90300438 |
| 137 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.90261341 |
| 138 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.89971529 |
| 139 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.89588695 |
| 140 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.89466979 |
| 141 | BCL6_25482012_ChIP-Seq_CML-JURL-MK1_Human | 0.86836843 |
| 142 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.85318098 |
| 143 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.85126881 |
| 144 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.84359497 |
| 145 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.81596563 |
| 146 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.79622473 |
| 147 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.77066665 |
| 148 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.76270666 |
| 149 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.75747350 |
| 150 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.75442895 |
| 151 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.75194264 |
| 152 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.73050232 |
| 153 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.71896949 |
| 154 | * NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.70479609 |
| 155 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.69491919 |
| 156 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.69384602 |
| 157 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.65747952 |
| 158 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.64480302 |
| 159 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.64419138 |
| 160 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.62673805 |
| 161 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.62330070 |
| 162 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.61821050 |
| 163 | * SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.61226225 |
| 164 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.61221014 |
| 165 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.60133408 |
| 166 | * MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.59314392 |
| 167 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.59056363 |
| 168 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.58452875 |
| 169 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.57622142 |
| 170 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.57534762 |
| 171 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.57457318 |
| 172 | GATA1_22025678_ChIP-Seq_K562_Human | 0.56896730 |
| 173 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.56525063 |
| 174 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.56169163 |
| 175 | * SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.55992172 |
| 176 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.55831900 |
| 177 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.55571211 |
| 178 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.55015301 |
| 179 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.54415509 |
| 180 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.53605780 |
| 181 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.53061405 |
| 182 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 0.52565407 |
| 183 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.52138996 |
| 184 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.51481050 |
| 185 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.51120630 |
| 186 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.50376142 |
| 187 | * SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.50092717 |
| 188 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.50048473 |
| 189 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.49992609 |
| 190 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.49793370 |
| 191 | FLI1_21867929_ChIP-Seq_CD8_Mouse | 0.47827643 |
| 192 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.47577316 |
| 193 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.47353324 |
| 194 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.47267149 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.55841533 |
| 2 | MP0005360_urolithiasis | 7.29575967 |
| 3 | MP0005365_abnormal_bile_salt | 6.29354898 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 6.11300819 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.47190656 |
| 6 | MP0003252_abnormal_bile_duct | 3.71931128 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.57165017 |
| 8 | MP0005332_abnormal_amino_acid | 3.32107406 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.30640876 |
| 10 | MP0004019_abnormal_vitamin_homeostasis | 2.82238987 |
| 11 | MP0003195_calcinosis | 2.75117886 |
| 12 | MP0001666_abnormal_nutrient_absorption | 2.47938378 |
| 13 | MP0009840_abnormal_foam_cell | 2.40927241 |
| 14 | MP0001968_abnormal_touch/_nociception | 2.40307729 |
| 15 | MP0005377_hearing/vestibular/ear_phenot | 2.38246658 |
| 16 | MP0003878_abnormal_ear_physiology | 2.38246658 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.36567666 |
| 18 | MP0005083_abnormal_biliary_tract | 2.21920439 |
| 19 | MP0002118_abnormal_lipid_homeostasis | 2.21720488 |
| 20 | MP0002102_abnormal_ear_morphology | 2.18835971 |
| 21 | MP0005551_abnormal_eye_electrophysiolog | 2.13742097 |
| 22 | MP0000609_abnormal_liver_physiology | 2.05542411 |
| 23 | MP0002653_abnormal_ependyma_morphology | 2.00826734 |
| 24 | MP0005670_abnormal_white_adipose | 2.00196409 |
| 25 | MP0009745_abnormal_behavioral_response | 1.97905910 |
| 26 | MP0002138_abnormal_hepatobiliary_system | 1.94707834 |
| 27 | MP0001501_abnormal_sleep_pattern | 1.88946421 |
| 28 | MP0001986_abnormal_taste_sensitivity | 1.87298685 |
| 29 | MP0002736_abnormal_nociception_after | 1.87280601 |
| 30 | MP0005319_abnormal_enzyme/_coenzyme | 1.79613464 |
| 31 | MP0001486_abnormal_startle_reflex | 1.79124872 |
| 32 | MP0001485_abnormal_pinna_reflex | 1.77984842 |
| 33 | MP0001764_abnormal_homeostasis | 1.70828159 |
| 34 | MP0004742_abnormal_vestibular_system | 1.70543144 |
| 35 | MP0003868_abnormal_feces_composition | 1.69766011 |
| 36 | MP0009643_abnormal_urine_homeostasis | 1.66776994 |
| 37 | MP0003787_abnormal_imprinting | 1.64989897 |
| 38 | MP0004885_abnormal_endolymph | 1.64629507 |
| 39 | MP0002064_seizures | 1.64214026 |
| 40 | MP0009046_muscle_twitch | 1.64079495 |
| 41 | MP0003635_abnormal_synaptic_transmissio | 1.58589815 |
| 42 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.57029568 |
| 43 | MP0002063_abnormal_learning/memory/cond | 1.54581379 |
| 44 | MP0002572_abnormal_emotion/affect_behav | 1.53696723 |
| 45 | MP0005646_abnormal_pituitary_gland | 1.52470913 |
| 46 | MP0002272_abnormal_nervous_system | 1.50754005 |
| 47 | MP0008877_abnormal_DNA_methylation | 1.50322113 |
| 48 | MP0001502_abnormal_circadian_rhythm | 1.49385877 |
| 49 | MP0003186_abnormal_redox_activity | 1.48272981 |
| 50 | MP0002735_abnormal_chemical_nociception | 1.46619045 |
| 51 | MP0004142_abnormal_muscle_tone | 1.44862497 |
| 52 | MP0008995_early_reproductive_senescence | 1.37560766 |
| 53 | MP0003136_yellow_coat_color | 1.35156363 |
| 54 | MP0003646_muscle_fatigue | 1.33179086 |
| 55 | MP0008872_abnormal_physiological_respon | 1.32429120 |
| 56 | MP0002638_abnormal_pupillary_reflex | 1.32300326 |
| 57 | MP0005451_abnormal_body_composition | 1.30010224 |
| 58 | MP0004130_abnormal_muscle_cell | 1.29613787 |
| 59 | MP0005666_abnormal_adipose_tissue | 1.28440427 |
| 60 | MP0005167_abnormal_blood-brain_barrier | 1.26207275 |
| 61 | MP0002277_abnormal_respiratory_mucosa | 1.23814486 |
| 62 | MP0001970_abnormal_pain_threshold | 1.21131950 |
| 63 | MP0002557_abnormal_social/conspecific_i | 1.20817630 |
| 64 | MP0002971_abnormal_brown_adipose | 1.18293143 |
| 65 | MP0004133_heterotaxia | 1.17813616 |
| 66 | MP0005423_abnormal_somatic_nervous | 1.16140208 |
| 67 | MP0005647_abnormal_sex_gland | 1.16085314 |
| 68 | MP0004924_abnormal_behavior | 1.14162752 |
| 69 | MP0005386_behavior/neurological_phenoty | 1.14162752 |
| 70 | MP0003880_abnormal_central_pattern | 1.14052130 |
| 71 | MP0000427_abnormal_hair_cycle | 1.13667282 |
| 72 | MP0003183_abnormal_peptide_metabolism | 1.13095356 |
| 73 | MP0000598_abnormal_liver_morphology | 1.12800436 |
| 74 | MP0002067_abnormal_sensory_capabilities | 1.11581240 |
| 75 | MP0002733_abnormal_thermal_nociception | 1.10972767 |
| 76 | MP0003122_maternal_imprinting | 1.07720664 |
| 77 | MP0001440_abnormal_grooming_behavior | 1.07299022 |
| 78 | MP0003879_abnormal_hair_cell | 1.06307088 |
| 79 | MP0003656_abnormal_erythrocyte_physiolo | 1.06067186 |
| 80 | MP0003011_delayed_dark_adaptation | 1.05148066 |
| 81 | MP0005636_abnormal_mineral_homeostasis | 1.04618464 |
| 82 | MP0001661_extended_life_span | 1.03090759 |
| 83 | MP0005220_abnormal_exocrine_pancreas | 1.01233465 |
| 84 | MP0002876_abnormal_thyroid_physiology | 1.00008616 |
| 85 | MP0000026_abnormal_inner_ear | 0.98297060 |
| 86 | MP0003705_abnormal_hypodermis_morpholog | 0.98023966 |
| 87 | MP0004381_abnormal_hair_follicle | 0.97861399 |
| 88 | MP0005253_abnormal_eye_physiology | 0.96628712 |
| 89 | MP0005058_abnormal_lysosome_morphology | 0.96020395 |
| 90 | MP0006036_abnormal_mitochondrial_physio | 0.95905851 |
| 91 | MP0001756_abnormal_urination | 0.95090894 |
| 92 | MP0000566_synostosis | 0.92576808 |
| 93 | MP0005334_abnormal_fat_pad | 0.90764305 |
| 94 | MP0004859_abnormal_synaptic_plasticity | 0.89157569 |
| 95 | MP0002796_impaired_skin_barrier | 0.88139976 |
| 96 | MP0001984_abnormal_olfaction | 0.86697135 |
| 97 | MP0004185_abnormal_adipocyte_glucose | 0.86686025 |
| 98 | MP0000685_abnormal_immune_system | 0.85898237 |
| 99 | MP0000955_abnormal_spinal_cord | 0.84656037 |
| 100 | MP0006276_abnormal_autonomic_nervous | 0.84612598 |
| 101 | MP0001663_abnormal_digestive_system | 0.84067502 |
| 102 | MP0005379_endocrine/exocrine_gland_phen | 0.83583040 |
| 103 | MP0002249_abnormal_larynx_morphology | 0.83132443 |
| 104 | MP0000631_abnormal_neuroendocrine_gland | 0.82281983 |
| 105 | MP0004043_abnormal_pH_regulation | 0.81836723 |
| 106 | MP0000778_abnormal_nervous_system | 0.81507436 |
| 107 | MP0005376_homeostasis/metabolism_phenot | 0.81000727 |
| 108 | MP0005535_abnormal_body_temperature | 0.80986425 |
| 109 | MP0009642_abnormal_blood_homeostasis | 0.80733460 |
| 110 | MP0001963_abnormal_hearing_physiology | 0.80092448 |
| 111 | MP0002078_abnormal_glucose_homeostasis | 0.79572481 |
| 112 | MP0002136_abnormal_kidney_physiology | 0.79232175 |
| 113 | MP0003137_abnormal_impulse_conducting | 0.78838162 |
| 114 | MP0004145_abnormal_muscle_electrophysio | 0.78819709 |
| 115 | MP0000639_abnormal_adrenal_gland | 0.78178553 |
| 116 | MP0002734_abnormal_mechanical_nocicepti | 0.77520104 |
| 117 | MP0002254_reproductive_system_inflammat | 0.77283573 |
| 118 | MP0005645_abnormal_hypothalamus_physiol | 0.76904459 |
| 119 | MP0003690_abnormal_glial_cell | 0.75480066 |
| 120 | MP0009115_abnormal_fat_cell | 0.75252088 |
| 121 | MP0003938_abnormal_ear_development | 0.74863289 |
| 122 | MP0002882_abnormal_neuron_morphology | 0.73530443 |
| 123 | MP0005084_abnormal_gallbladder_morpholo | 0.73193674 |
| 124 | MP0002933_joint_inflammation | 0.73069324 |
| 125 | MP0009697_abnormal_copulation | 0.71498075 |
| 126 | MP0002060_abnormal_skin_morphology | 0.71336437 |
| 127 | MP0005266_abnormal_metabolism | 0.70530075 |
| 128 | MP0009763_increased_sensitivity_to | 0.70139487 |
| 129 | MP0005395_other_phenotype | 0.69177452 |
| 130 | MP0009764_decreased_sensitivity_to | 0.68347460 |
| 131 | MP0005195_abnormal_posterior_eye | 0.67318216 |
| 132 | MP0002909_abnormal_adrenal_gland | 0.66724850 |
| 133 | MP0002168_other_aberrant_phenotype | 0.65215319 |
| 134 | MP0008469_abnormal_protein_level | 0.65176931 |
| 135 | MP0008438_abnormal_cutaneous_collagen | 0.65134767 |
| 136 | MP0005375_adipose_tissue_phenotype | 0.64857324 |
| 137 | MP0003638_abnormal_response/metabolism_ | 0.64788991 |
| 138 | MP0002970_abnormal_white_adipose | 0.61513954 |
| 139 | MP0009278_abnormal_bone_marrow | 0.60340055 |
| 140 | MP0000579_abnormal_nail_morphology | 0.60142403 |
| 141 | MP0003453_abnormal_keratinocyte_physiol | 0.59780393 |
| 142 | MP0005408_hypopigmentation | 0.57702630 |
| 143 | MP0009765_abnormal_xenobiotic_induced | 0.56704140 |
| 144 | MP0003959_abnormal_lean_body | 0.54833265 |
| 145 | MP0005448_abnormal_energy_balance | 0.54776440 |
| 146 | MP0000604_amyloidosis | 0.54761299 |
| 147 | MP0002928_abnormal_bile_duct | 0.54512022 |
| 148 | MP0004264_abnormal_extraembryonic_tissu | 0.53462666 |
| 149 | MP0009053_abnormal_anal_canal | 0.52664016 |
| 150 | MP0003718_maternal_effect | 0.51578688 |
| 151 | MP0001765_abnormal_ion_homeostasis | 0.50391524 |
| 152 | MP0002282_abnormal_trachea_morphology | 0.49710402 |
| 153 | MP0003953_abnormal_hormone_level | 0.48405786 |
| 154 | MP0010368_abnormal_lymphatic_system | 0.46541423 |
| 155 | MP0005075_abnormal_melanosome_morpholog | 0.46114562 |
| 156 | MP0003724_increased_susceptibility_to | 0.44606024 |
| 157 | MP0004147_increased_porphyrin_level | 0.40787317 |
| 158 | MP0008874_decreased_physiological_sensi | 0.39993045 |
| 159 | MP0002135_abnormal_kidney_morphology | 0.39565974 |
| 160 | MP0003075_altered_response_to | 0.39403144 |
| 161 | MP0010030_abnormal_orbit_morphology | 0.38853490 |
| 162 | MP0000467_abnormal_esophagus_morphology | 0.37739340 |
| 163 | MP0002295_abnormal_pulmonary_circulatio | 0.35899054 |
| 164 | MP0001324_abnormal_eye_pigmentation | 0.35890234 |
| 165 | MP0003172_abnormal_lysosome_physiology | 0.35844693 |
| 166 | MP0006035_abnormal_mitochondrial_morpho | 0.35579547 |
| 167 | MP0000538_abnormal_urinary_bladder | 0.35076759 |
| 168 | MP0000230_abnormal_systemic_arterial | 0.35018721 |
| 169 | MP0001340_abnormal_eyelid_morphology | 0.33007197 |
| 170 | MP0000371_diluted_coat_color | 0.32893454 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.64318464 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.53416774 |
| 3 | Deep venous thrombosis (HP:0002625) | 5.83981390 |
| 4 | Xanthomatosis (HP:0000991) | 5.59795205 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.48892447 |
| 6 | Hyperglycinuria (HP:0003108) | 5.12733988 |
| 7 | Complement deficiency (HP:0004431) | 5.02958424 |
| 8 | Hypobetalipoproteinemia (HP:0003563) | 4.95127069 |
| 9 | Prolonged partial thromboplastin time (HP:0003645) | 4.89122771 |
| 10 | Ketosis (HP:0001946) | 4.76754279 |
| 11 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.76416738 |
| 12 | Abnormality of glycine metabolism (HP:0010895) | 4.76416738 |
| 13 | Hyperammonemia (HP:0001987) | 4.71829611 |
| 14 | Hyperglycinemia (HP:0002154) | 4.66839851 |
| 15 | Hyperlipoproteinemia (HP:0010980) | 4.51503181 |
| 16 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.50407078 |
| 17 | Attenuation of retinal blood vessels (HP:0007843) | 4.13709365 |
| 18 | Ketoacidosis (HP:0001993) | 4.07527990 |
| 19 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.07034964 |
| 20 | Congenital stationary night blindness (HP:0007642) | 3.98595272 |
| 21 | Concave nail (HP:0001598) | 3.95919798 |
| 22 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.93109110 |
| 23 | Hypolipoproteinemia (HP:0010981) | 3.88457256 |
| 24 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.82779394 |
| 25 | Epidermoid cyst (HP:0200040) | 3.80185516 |
| 26 | Joint hemorrhage (HP:0005261) | 3.79527176 |
| 27 | Pancreatic cysts (HP:0001737) | 3.69067535 |
| 28 | Fat malabsorption (HP:0002630) | 3.66832191 |
| 29 | Molar tooth sign on MRI (HP:0002419) | 3.64625390 |
| 30 | Abnormality of midbrain morphology (HP:0002418) | 3.64625390 |
| 31 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.64094964 |
| 32 | Hypoglycemic coma (HP:0001325) | 3.63810392 |
| 33 | Ependymoma (HP:0002888) | 3.62643620 |
| 34 | Abnormality of complement system (HP:0005339) | 3.62253525 |
| 35 | Abnormality of methionine metabolism (HP:0010901) | 3.57075348 |
| 36 | Hypoalphalipoproteinemia (HP:0003233) | 3.55345045 |
| 37 | Gout (HP:0001997) | 3.45839574 |
| 38 | True hermaphroditism (HP:0010459) | 3.40210920 |
| 39 | Delayed CNS myelination (HP:0002188) | 3.38392398 |
| 40 | Pancreatic fibrosis (HP:0100732) | 3.37489960 |
| 41 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.26988617 |
| 42 | Abnormality of the common coagulation pathway (HP:0010990) | 3.25749606 |
| 43 | Abnormality of the renal cortex (HP:0011035) | 3.22931741 |
| 44 | Nephronophthisis (HP:0000090) | 3.20956654 |
| 45 | Abnormality of alanine metabolism (HP:0010916) | 3.18765021 |
| 46 | Hyperalaninemia (HP:0003348) | 3.18765021 |
| 47 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.18765021 |
| 48 | Hypochromic microcytic anemia (HP:0004840) | 3.15377209 |
| 49 | Abnormality of purine metabolism (HP:0004352) | 3.14342276 |
| 50 | Abnormality of nucleobase metabolism (HP:0010932) | 3.09896114 |
| 51 | Abnormality of serum amino acid levels (HP:0003112) | 3.03336688 |
| 52 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.02376450 |
| 53 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.01003791 |
| 54 | Hyperventilation (HP:0002883) | 3.00598541 |
| 55 | Abnormality of the renal medulla (HP:0100957) | 2.97148147 |
| 56 | Pendular nystagmus (HP:0012043) | 2.97026616 |
| 57 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.96336443 |
| 58 | Dicarboxylic aciduria (HP:0003215) | 2.96336443 |
| 59 | Abnormality of the intrinsic pathway (HP:0010989) | 2.95821897 |
| 60 | Focal motor seizures (HP:0011153) | 2.95345578 |
| 61 | Myocardial infarction (HP:0001658) | 2.93579627 |
| 62 | Steatorrhea (HP:0002570) | 2.88721897 |
| 63 | Lethargy (HP:0001254) | 2.86517574 |
| 64 | Type II lissencephaly (HP:0007260) | 2.84458351 |
| 65 | Hypercholesterolemia (HP:0003124) | 2.83856909 |
| 66 | Cystic liver disease (HP:0006706) | 2.82586175 |
| 67 | Conjugated hyperbilirubinemia (HP:0002908) | 2.81796634 |
| 68 | Turricephaly (HP:0000262) | 2.80456285 |
| 69 | Metabolic acidosis (HP:0001942) | 2.80304408 |
| 70 | Prolonged QT interval (HP:0001657) | 2.77929015 |
| 71 | Generalized aminoaciduria (HP:0002909) | 2.76763956 |
| 72 | Hyperbilirubinemia (HP:0002904) | 2.68236467 |
| 73 | Hepatocellular carcinoma (HP:0001402) | 2.64655883 |
| 74 | Chronic hepatic failure (HP:0100626) | 2.59448172 |
| 75 | Febrile seizures (HP:0002373) | 2.59331299 |
| 76 | Myositis (HP:0100614) | 2.58545543 |
| 77 | Birth length less than 3rd percentile (HP:0003561) | 2.58149048 |
| 78 | Progressive cerebellar ataxia (HP:0002073) | 2.53317415 |
| 79 | Proximal tubulopathy (HP:0000114) | 2.51906595 |
| 80 | Increased purine levels (HP:0004368) | 2.50920808 |
| 81 | Hyperuricemia (HP:0002149) | 2.50920808 |
| 82 | Focal seizures (HP:0007359) | 2.49619913 |
| 83 | Atonic seizures (HP:0010819) | 2.48149539 |
| 84 | Irritability (HP:0000737) | 2.46967615 |
| 85 | Vascular calcification (HP:0004934) | 2.46818210 |
| 86 | Malnutrition (HP:0004395) | 2.45876567 |
| 87 | Inability to walk (HP:0002540) | 2.44758892 |
| 88 | Agnosia (HP:0010524) | 2.44380795 |
| 89 | Spastic diplegia (HP:0001264) | 2.42745444 |
| 90 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.41809954 |
| 91 | Systemic lupus erythematosus (HP:0002725) | 2.40543530 |
| 92 | Alkalosis (HP:0001948) | 2.40528514 |
| 93 | Gait imbalance (HP:0002141) | 2.39756941 |
| 94 | Vomiting (HP:0002013) | 2.39459509 |
| 95 | Orchitis (HP:0100796) | 2.38866556 |
| 96 | Abnormality of proline metabolism (HP:0010907) | 2.37083495 |
| 97 | Hydroxyprolinuria (HP:0003080) | 2.37083495 |
| 98 | Astrocytoma (HP:0009592) | 2.35825413 |
| 99 | Abnormality of the astrocytes (HP:0100707) | 2.35825413 |
| 100 | 3-Methylglutaconic aciduria (HP:0003535) | 2.35393218 |
| 101 | Skin nodule (HP:0200036) | 2.32614954 |
| 102 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.32244601 |
| 103 | Rickets (HP:0002748) | 2.31953605 |
| 104 | Enlarged kidneys (HP:0000105) | 2.31697871 |
| 105 | Keratoconus (HP:0000563) | 2.30900572 |
| 106 | Increased corneal curvature (HP:0100692) | 2.30900572 |
| 107 | Cerebral edema (HP:0002181) | 2.28100167 |
| 108 | Opisthotonus (HP:0002179) | 2.27861268 |
| 109 | Abnormality of urine glucose concentration (HP:0011016) | 2.27790353 |
| 110 | Glycosuria (HP:0003076) | 2.27790353 |
| 111 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.24473688 |
| 112 | Pachygyria (HP:0001302) | 2.23504482 |
| 113 | Occipital encephalocele (HP:0002085) | 2.23201933 |
| 114 | Constricted visual fields (HP:0001133) | 2.22297314 |
| 115 | Severe muscular hypotonia (HP:0006829) | 2.22189497 |
| 116 | Cardiovascular calcification (HP:0011915) | 2.21707057 |
| 117 | Neonatal onset (HP:0003623) | 2.21347555 |
| 118 | Pancreatitis (HP:0001733) | 2.19435880 |
| 119 | Spontaneous abortion (HP:0005268) | 2.18450994 |
| 120 | Tubular atrophy (HP:0000092) | 2.17716202 |
| 121 | Polyphagia (HP:0002591) | 2.17673798 |
| 122 | Optic neuritis (HP:0100653) | 2.17651752 |
| 123 | Retrobulbar optic neuritis (HP:0100654) | 2.17651752 |
| 124 | Medial flaring of the eyebrow (HP:0010747) | 2.17188417 |
| 125 | Nephrogenic diabetes insipidus (HP:0009806) | 2.14348049 |
| 126 | Lissencephaly (HP:0001339) | 2.14059426 |
| 127 | Fair hair (HP:0002286) | 2.13047272 |
| 128 | Amyloidosis (HP:0011034) | 2.12951211 |
| 129 | Supernumerary spleens (HP:0009799) | 2.10973347 |
| 130 | Arthropathy (HP:0003040) | 2.09913537 |
| 131 | Congenital sensorineural hearing impairment (HP:0008527) | 2.09709227 |
| 132 | Polydipsia (HP:0001959) | 2.06699717 |
| 133 | Abnormal drinking behavior (HP:0030082) | 2.06699717 |
| 134 | Patellar aplasia (HP:0006443) | 2.04714253 |
| 135 | Stomatitis (HP:0010280) | 2.04552574 |
| 136 | Abnormal hemoglobin (HP:0011902) | 2.04437196 |
| 137 | Genetic anticipation (HP:0003743) | 2.04376986 |
| 138 | Recurrent corneal erosions (HP:0000495) | 2.04262365 |
| 139 | Optic disc pallor (HP:0000543) | 2.03638774 |
| 140 | Brushfield spots (HP:0001088) | 2.00884457 |
| 141 | Decreased circulating renin level (HP:0003351) | 2.00836564 |
| 142 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.00371318 |
| 143 | Sensorimotor neuropathy (HP:0007141) | 2.00057561 |
| 144 | Peritonitis (HP:0002586) | 1.99955194 |
| 145 | Alopecia of scalp (HP:0002293) | 1.99833326 |
| 146 | Bile duct proliferation (HP:0001408) | 1.99226440 |
| 147 | Abnormal biliary tract physiology (HP:0012439) | 1.99226440 |
| 148 | Neoplasm of the oral cavity (HP:0100649) | 1.98637077 |
| 149 | Abnormal EKG (HP:0003115) | 1.97619024 |
| 150 | Congenital primary aphakia (HP:0007707) | 1.96812070 |
| 151 | Hemorrhage of the eye (HP:0011885) | 1.95900598 |
| 152 | Abnormal cartilage morphology (HP:0002763) | 1.95438129 |
| 153 | Hypoglycemic seizures (HP:0002173) | 1.93122062 |
| 154 | Esophageal varix (HP:0002040) | 1.92439578 |
| 155 | Tented upper lip vermilion (HP:0010804) | 1.92016121 |
| 156 | Menorrhagia (HP:0000132) | 1.91557907 |
| 157 | Late onset (HP:0003584) | 1.91479099 |
| 158 | Oligomenorrhea (HP:0000876) | 1.90987986 |
| 159 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.90874446 |
| 160 | Cerebral palsy (HP:0100021) | 1.89443347 |
| 161 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.89388790 |
| 162 | Generalized hypopigmentation of hair (HP:0011358) | 1.88475382 |
| 163 | Decreased central vision (HP:0007663) | 1.87526749 |
| 164 | Cerebellar dysplasia (HP:0007033) | 1.87438473 |
| 165 | Acute hepatic failure (HP:0006554) | 1.87296161 |
| 166 | Nephrolithiasis (HP:0000787) | 1.83603648 |
| 167 | Oligodactyly (hands) (HP:0001180) | 1.82289070 |
| 168 | Broad-based gait (HP:0002136) | 1.80636952 |
| 169 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.79958282 |
| 170 | Mucopolysacchariduria (HP:0008155) | 1.79923883 |
| 171 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.79923883 |
| 172 | Hypertriglyceridemia (HP:0002155) | 1.79899036 |
| 173 | Congenital hepatic fibrosis (HP:0002612) | 1.79892935 |
| 174 | Biliary tract neoplasm (HP:0100574) | 1.79778710 |
| 175 | Absent speech (HP:0001344) | 1.78968685 |
| 176 | Hemoptysis (HP:0002105) | 1.78667809 |
| 177 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.78431693 |
| 178 | Glioma (HP:0009733) | 1.77392021 |
| 179 | Abnormal gallbladder morphology (HP:0012437) | 1.77303551 |
| 180 | Anencephaly (HP:0002323) | 1.76666646 |
| 181 | Hypoplastic iliac wings (HP:0002866) | 1.75510598 |
| 182 | Nausea (HP:0002018) | 1.74797819 |
| 183 | Renal cortical cysts (HP:0000803) | 1.74507810 |
| 184 | Glomerulonephritis (HP:0000099) | 1.72821464 |
| 185 | Clumsiness (HP:0002312) | 1.72264406 |
| 186 | Elevated hepatic transaminases (HP:0002910) | 1.72161425 |
| 187 | Large for gestational age (HP:0001520) | 1.71914174 |
| 188 | Mitral stenosis (HP:0001718) | 1.71711529 |
| 189 | Epileptic encephalopathy (HP:0200134) | 1.71656400 |
| 190 | Papilledema (HP:0001085) | 1.71281625 |
| 191 | Tachypnea (HP:0002789) | 1.71070097 |
| 192 | Abnormality of vitamin metabolism (HP:0100508) | 1.71013058 |
| 193 | Sleep apnea (HP:0010535) | 1.70365317 |
| 194 | Stomach cancer (HP:0012126) | 1.69762842 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.59189450 |
| 2 | MAPK15 | 4.54415559 |
| 3 | ICK | 3.99538934 |
| 4 | SIK1 | 3.28650515 |
| 5 | MAP3K6 | 3.14453166 |
| 6 | PINK1 | 2.92796945 |
| 7 | DDR2 | 2.88188373 |
| 8 | ERN1 | 2.72776902 |
| 9 | FGFR4 | 2.58964415 |
| 10 | MARK1 | 2.54966993 |
| 11 | MAP4K2 | 2.54816118 |
| 12 | DAPK2 | 2.43170477 |
| 13 | TNK2 | 2.17795496 |
| 14 | MAP3K11 | 2.07080026 |
| 15 | MAPK13 | 2.05714578 |
| 16 | MAPK11 | 1.98673416 |
| 17 | ADRBK2 | 1.97190278 |
| 18 | INSRR | 1.85683383 |
| 19 | OXSR1 | 1.82280273 |
| 20 | TRIB3 | 1.80369963 |
| 21 | ERBB4 | 1.80249449 |
| 22 | WNK4 | 1.78697879 |
| 23 | CSK | 1.76704386 |
| 24 | TYRO3 | 1.73137824 |
| 25 | WNK3 | 1.70908733 |
| 26 | LATS1 | 1.70087762 |
| 27 | PRKD2 | 1.66140883 |
| 28 | SIK2 | 1.64278576 |
| 29 | MATK | 1.58987088 |
| 30 | NTRK3 | 1.54186339 |
| 31 | FGR | 1.53966733 |
| 32 | MAP2K6 | 1.48889063 |
| 33 | DYRK1B | 1.46762679 |
| 34 | PDGFRA | 1.43462468 |
| 35 | ACVR1B | 1.42091464 |
| 36 | PRKAA2 | 1.40235115 |
| 37 | DYRK2 | 1.39806949 |
| 38 | GRK1 | 1.38608386 |
| 39 | FLT3 | 1.36792514 |
| 40 | BMX | 1.35235522 |
| 41 | GSK3A | 1.33365104 |
| 42 | NTRK2 | 1.32500222 |
| 43 | MST1R | 1.32298069 |
| 44 | EPHB1 | 1.29805604 |
| 45 | STK38L | 1.26919117 |
| 46 | PAK3 | 1.24876447 |
| 47 | CAMK1 | 1.20805662 |
| 48 | RIPK4 | 1.20426294 |
| 49 | BMPR1B | 1.19500023 |
| 50 | TAOK3 | 1.19416369 |
| 51 | CDK6 | 1.16835844 |
| 52 | RIPK1 | 1.13286774 |
| 53 | MAP4K1 | 1.09095419 |
| 54 | KIT | 1.08639983 |
| 55 | PAK4 | 1.05803606 |
| 56 | STK39 | 1.05422068 |
| 57 | MARK2 | 1.05244826 |
| 58 | CAMK1D | 1.02875693 |
| 59 | MAP3K4 | 1.01012917 |
| 60 | ADRBK1 | 1.00957038 |
| 61 | CASK | 0.97576269 |
| 62 | PRKAA1 | 0.97413859 |
| 63 | MAPK12 | 0.92597714 |
| 64 | PTK2B | 0.90542404 |
| 65 | STK11 | 0.89610895 |
| 66 | DAPK1 | 0.87228321 |
| 67 | TXK | 0.86281654 |
| 68 | IRAK4 | 0.84869372 |
| 69 | LATS2 | 0.83437222 |
| 70 | AKT3 | 0.83367931 |
| 71 | DYRK1A | 0.83072155 |
| 72 | CAMKK2 | 0.81180807 |
| 73 | PRKCG | 0.80755062 |
| 74 | CSNK1G1 | 0.79523123 |
| 75 | TGFBR2 | 0.79174341 |
| 76 | MAP3K3 | 0.79030909 |
| 77 | MET | 0.76879531 |
| 78 | ABL2 | 0.76243611 |
| 79 | PTK2 | 0.75246914 |
| 80 | CAMK2G | 0.73578976 |
| 81 | CAMKK1 | 0.73287343 |
| 82 | TIE1 | 0.73090382 |
| 83 | PKN1 | 0.73011829 |
| 84 | JAK2 | 0.72782811 |
| 85 | MAP2K4 | 0.71010453 |
| 86 | BLK | 0.70795344 |
| 87 | ZAP70 | 0.68139883 |
| 88 | FGFR2 | 0.67420571 |
| 89 | MAPK4 | 0.66802235 |
| 90 | CAMK4 | 0.66598097 |
| 91 | YES1 | 0.65957731 |
| 92 | PIK3CA | 0.65346787 |
| 93 | SYK | 0.64081453 |
| 94 | JAK3 | 0.63774147 |
| 95 | PKN2 | 0.62440164 |
| 96 | TLK1 | 0.61911791 |
| 97 | PRKCZ | 0.61788881 |
| 98 | UHMK1 | 0.60736158 |
| 99 | SGK494 | 0.60373655 |
| 100 | SGK223 | 0.60373655 |
| 101 | EPHA3 | 0.57977355 |
| 102 | TAOK1 | 0.56666244 |
| 103 | TRPM7 | 0.56525782 |
| 104 | SGK2 | 0.56291424 |
| 105 | IKBKE | 0.56187826 |
| 106 | MTOR | 0.55956059 |
| 107 | PIK3CG | 0.54861557 |
| 108 | MAP2K7 | 0.53645979 |
| 109 | DYRK3 | 0.53568094 |
| 110 | MAP3K10 | 0.53448853 |
| 111 | PRKCQ | 0.52857360 |
| 112 | FES | 0.51945295 |
| 113 | NME1 | 0.51841598 |
| 114 | PRKACG | 0.51738587 |
| 115 | RPS6KC1 | 0.51483202 |
| 116 | RPS6KL1 | 0.51483202 |
| 117 | PRKCE | 0.51462645 |
| 118 | PTK6 | 0.51078744 |
| 119 | LCK | 0.50923206 |
| 120 | MAPKAPK3 | 0.49656185 |
| 121 | MARK3 | 0.48914920 |
| 122 | CDK7 | 0.48427356 |
| 123 | ERBB2 | 0.48082390 |
| 124 | PIM1 | 0.47987952 |
| 125 | HCK | 0.47393955 |
| 126 | MUSK | 0.47338008 |
| 127 | PIM2 | 0.47216306 |
| 128 | NLK | 0.46869579 |
| 129 | PDK4 | 0.46581954 |
| 130 | PDK3 | 0.46581954 |
| 131 | TAOK2 | 0.45502282 |
| 132 | MAP3K7 | 0.44409673 |
| 133 | CSNK1D | 0.44235440 |
| 134 | RPS6KA6 | 0.44090152 |
| 135 | CDK5 | 0.43785634 |
| 136 | MAP2K2 | 0.43449271 |
| 137 | CAMK2A | 0.43095058 |
| 138 | MAP2K3 | 0.42896648 |
| 139 | RET | 0.42669603 |
| 140 | CAMK1G | 0.42203394 |
| 141 | PNCK | 0.41361673 |
| 142 | EPHA4 | 0.41360759 |
| 143 | IRAK1 | 0.41287978 |
| 144 | IKBKB | 0.40121009 |
| 145 | CSF1R | 0.40066266 |
| 146 | FRK | 0.38194168 |
| 147 | IRAK2 | 0.37521926 |
| 148 | PDPK1 | 0.34436695 |
| 149 | EGFR | 0.34013947 |
| 150 | NEK9 | 0.33129580 |
| 151 | TYK2 | 0.32908225 |
| 152 | MAPK3 | 0.32622427 |
| 153 | STK3 | 0.31005997 |
| 154 | PHKG2 | 0.30750706 |
| 155 | PHKG1 | 0.30750706 |
| 156 | PRKD1 | 0.27896498 |
| 157 | INSR | 0.26280270 |
| 158 | RPS6KA1 | 0.26258165 |
| 159 | LYN | 0.25159156 |
| 160 | STK38 | 0.24489467 |
| 161 | ABL1 | 0.24202083 |
| 162 | GRK6 | 0.23945305 |
| 163 | PDGFRB | 0.23666554 |
| 164 | PDK2 | 0.23382786 |
| 165 | CSNK1G3 | 0.23207644 |
| 166 | RPS6KB1 | 0.22937536 |
| 167 | HIPK2 | 0.21106131 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.09594318 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.15640271 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 2.97075226 |
| 4 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.89162980 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.86365188 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.77126927 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.74306074 |
| 8 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.72065523 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.63992338 |
| 10 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.63284856 |
| 11 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.60684591 |
| 12 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.53409465 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.50886852 |
| 14 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.49574391 |
| 15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.47098812 |
| 16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.43943036 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 2.30942853 |
| 18 | Morphine addiction_Homo sapiens_hsa05032 | 2.26831984 |
| 19 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.24969009 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.10301587 |
| 21 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.09477666 |
| 22 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.95374304 |
| 23 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.89439910 |
| 24 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.89056874 |
| 25 | Phototransduction_Homo sapiens_hsa04744 | 1.88396968 |
| 26 | GABAergic synapse_Homo sapiens_hsa04727 | 1.88320150 |
| 27 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.85909957 |
| 28 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.81609535 |
| 29 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.73874499 |
| 30 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.70519849 |
| 31 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.68394826 |
| 32 | Circadian entrainment_Homo sapiens_hsa04713 | 1.66768209 |
| 33 | Histidine metabolism_Homo sapiens_hsa00340 | 1.64572114 |
| 34 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.63986943 |
| 35 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.63387370 |
| 36 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.63024261 |
| 37 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.62103905 |
| 38 | Taste transduction_Homo sapiens_hsa04742 | 1.59629881 |
| 39 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.57620445 |
| 40 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.53840613 |
| 41 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.53325811 |
| 42 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.52126331 |
| 43 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.47494087 |
| 44 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.46604059 |
| 45 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.45110576 |
| 46 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.44256430 |
| 47 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.42923594 |
| 48 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.41830330 |
| 49 | Retinol metabolism_Homo sapiens_hsa00830 | 1.41206928 |
| 50 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.40616218 |
| 51 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.36686456 |
| 52 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.35434501 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.31192443 |
| 54 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.30374785 |
| 55 | Bile secretion_Homo sapiens_hsa04976 | 1.30317040 |
| 56 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.30127733 |
| 57 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.30085831 |
| 58 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.29376649 |
| 59 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.24359856 |
| 60 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.23092412 |
| 61 | Carbon metabolism_Homo sapiens_hsa01200 | 1.22631576 |
| 62 | Sulfur relay system_Homo sapiens_hsa04122 | 1.21074820 |
| 63 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.19924867 |
| 64 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.17954188 |
| 65 | * Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.15349834 |
| 66 | Lysine degradation_Homo sapiens_hsa00310 | 1.13880083 |
| 67 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.13491185 |
| 68 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.12924744 |
| 69 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.12147327 |
| 70 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.08384598 |
| 71 | ABC transporters_Homo sapiens_hsa02010 | 1.06688238 |
| 72 | Insulin secretion_Homo sapiens_hsa04911 | 1.04191539 |
| 73 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.02343228 |
| 74 | Cocaine addiction_Homo sapiens_hsa05030 | 0.98452642 |
| 75 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.98372212 |
| 76 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.96114115 |
| 77 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.95941763 |
| 78 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.94262824 |
| 79 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.94175529 |
| 80 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.94004112 |
| 81 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.93491903 |
| 82 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.91185917 |
| 83 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.88269681 |
| 84 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.86725889 |
| 85 | Olfactory transduction_Homo sapiens_hsa04740 | 0.83675486 |
| 86 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.83072668 |
| 87 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.80246818 |
| 88 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.79015572 |
| 89 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.77140913 |
| 90 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.76377657 |
| 91 | Axon guidance_Homo sapiens_hsa04360 | 0.74934315 |
| 92 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.74216558 |
| 93 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.73292966 |
| 94 | Salivary secretion_Homo sapiens_hsa04970 | 0.71586482 |
| 95 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.68964651 |
| 96 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.68751044 |
| 97 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.61883140 |
| 98 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.60420436 |
| 99 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.60014239 |
| 100 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.59336387 |
| 101 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.58527778 |
| 102 | Long-term depression_Homo sapiens_hsa04730 | 0.58243110 |
| 103 | Renin secretion_Homo sapiens_hsa04924 | 0.53911415 |
| 104 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.52782549 |
| 105 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.52744349 |
| 106 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.51883955 |
| 107 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.48783542 |
| 108 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.46333001 |
| 109 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.45447712 |
| 110 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.45228196 |
| 111 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.43778633 |
| 112 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.43742734 |
| 113 | Parkinsons disease_Homo sapiens_hsa05012 | 0.42923514 |
| 114 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.42902559 |
| 115 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.42502069 |
| 116 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.42431372 |
| 117 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.41728969 |
| 118 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.39922261 |
| 119 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.36242019 |
| 120 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.33249533 |
| 121 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.32633937 |
| 122 | Alzheimers disease_Homo sapiens_hsa05010 | 0.32394526 |
| 123 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.32379499 |
| 124 | Prion diseases_Homo sapiens_hsa05020 | 0.31039253 |
| 125 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.30708456 |
| 126 | Galactose metabolism_Homo sapiens_hsa00052 | 0.27035640 |
| 127 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.26095310 |
| 128 | Insulin resistance_Homo sapiens_hsa04931 | 0.20915898 |
| 129 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.17918088 |
| 130 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.14391915 |
| 131 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.13582088 |
| 132 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.13330602 |
| 133 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.09648885 |
| 134 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.09549742 |
| 135 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.05697577 |
| 136 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.01909756 |
| 137 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.01625764 |
| 138 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.00317728 |
| 139 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.1763558 |
| 140 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | -0.1746106 |
| 141 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1719550 |
| 142 | Notch signaling pathway_Homo sapiens_hsa04330 | -0.1708693 |
| 143 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1575811 |
| 144 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1560349 |
| 145 | Mineral absorption_Homo sapiens_hsa04978 | -0.1397228 |
| 146 | Other glycan degradation_Homo sapiens_hsa00511 | -0.1331687 |
| 147 | Lysosome_Homo sapiens_hsa04142 | -0.1231138 |
| 148 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | -0.1189653 |
| 149 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0813202 |
| 150 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | -0.0463094 |
| 151 | Bladder cancer_Homo sapiens_hsa05219 | -0.0326314 |
| 152 | Circadian rhythm_Homo sapiens_hsa04710 | -0.0131906 |
| 153 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0023126 |

